Upstream Bio, Inc. (UPB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $117.84M
Last updated: Nov 17, 2026 at 4:10 PM ET
Upstream Bio, Inc. (UPB) Statistics
Upstream Bio (UPB) has a market cap of $117.84M and an enterprise value of $70.43M. It kept -5712.33% of revenue as net income over the last 12 months. It holds $47.42M more cash than debt, 40.24% of its market cap.
Total Valuation
Enterprise value is 40.24% below the market cap, as cash exceeds debt.
| Market Cap | $117.84M |
|---|---|
| Enterprise Value | $70.43M |
| Latest price (Nov 17, 2026) | $2.10 |
Key Dates
The next earnings report is expected on Mar 24, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 24, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 10, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 40.1x and 0.5x.
| P/S Ratio | 40.1x |
|---|---|
| Forward P/S | 47.7x |
| P/B Ratio | 0.5x |
Price Statistics
The stock is down 91.44% over 52 weeks and trades 48.53% below its 50-day average.
| Beta (1Y) | 1.83 |
|---|---|
| 52-Week Change | -91.44% |
| 1-Month Change | -25.00% |
| 3-Month Change | -72.06% |
| 6-Month Change | -73.85% |
| Total Return (1Y) | -91.44% |
| Return vs SPY (1Y) | -103.34% |
| Max Drawdown (1Y) | -93.56% |
| Max Drawdown (3Y) | -93.56% |
| Sharpe Ratio (1Y) | -2.33 |
| Correlation with SPY (1Y) | 0.23 |
| 50-Day Average | $4.08 |
| 200-Day Average | $7.60 |
| 52-Week Range | $2.12 to $33.68 |
| RSI (14 Days) | 27.6 |
| Average Volume (20 Days) | 1.30M |
Financial Position
Current assets cover 20.45x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 20.45x |
|---|---|
| Quick Ratio | 20.45x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -70.07% and return on assets is -66.65% over the last 12 months.
| Return on Equity (ROE) | -70.07% |
|---|---|
| Return on Assets (ROA) | -66.65% |
| Asset Turnover | 0.01x |
| Receivables Turnover | 4.92x |
Scores
UPB has an Altman Z-Score of 1.94, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 1.94 |
|---|---|
| Altman Z Zone | Grey |
| Piotroski F-Score | 2 of 9 |
| Piotroski Strength | Weak |
Income Statement
Revenue of $2.87M over the last 12 months is up 2.54% from the 12 months before.
| Revenue | $2.87M |
|---|---|
| Revenue Growth (YoY) | +2.54% |
| Gross Profit | $2.87M |
| Operating Income | -$175.53M |
| Pretax Income | -$163.94M |
| Net Income | -$163.94M |
| Reported EPS (TTM) | -$3.01 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 95.11% of the $245.99M in total assets.
| Cash and Equivalents | $47.42M |
|---|---|
| Total Debt | $0 |
| Net Cash | $47.42M |
| Net Cash Per Share | $0.87 |
| Working Capital | $232.67M |
| Shareholder Equity | $233.97M |
| Book Value Per Share | $4.27 |
| Total Assets | $245.99M |
| Total Liabilities | $12.02M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$168.33M |
|---|---|
| FCF Per Share | -$3.07 |
| Depreciation and Amortization | $2.79M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -6115.99%.
| Gross Margin | 100.00% |
|---|---|
| Operating Margin | -6115.99% |
| Pretax Margin | -5712.33% |
| Net Margin | -5712.33% |
Dividends and Yields
UPB does not pay a dividend.
| Buyback Yield | -0.06% |
|---|---|
| Shareholder Yield | -0.06% |
Peer Position
Against 7 similar companies, UPB has the 4th highest P/S.
P/S RatioPeer median 16.9x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median -46.46%
| P/S Ratio | 40.1x vs 16.9x median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | +2.54% vs -46.46% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About UPB
What is UPB's market cap?
Upstream Bio has a market cap of $117.84M. Its enterprise value, which adds debt and subtracts cash, is $70.43M.
How many shares of UPB are outstanding?
Upstream Bio has 54.78M shares outstanding. The count is up 1.58% from a year earlier.
Does UPB pay a dividend?
No. Upstream Bio does not pay a dividend.
How much debt does UPB have?
Upstream Bio has $0 of total debt and $47.42M of cash and equivalents, a net cash position of $47.42M.
UPB pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors